---
title: The Intel - 0125
---

Celebrating scientific impact and collaboration, our innovations and launches, and special features and resources

| View in browser As we step into 2025, we at Visiopharm want to take a moment to reflect on the remarkable milestones we achieved in 2024, all thanks to your support. This January's edition of The Intel is dedicated to celebrating these accomplishments and setting our sights on future innovations. 2024 highlights in numbers We're thrilled to share that over 550 scientific publications mentioned Visiopharm's software in 2024. This significant milestone underscores our commitment to advancing scientific discovery and our contribution to the broader scientific community. Explore our handpicked selection of impactful research here.   Connecting in person 2024 was a year of active engagement for us. We hit the road, attended various industry events, and engaged directly with our valued customers and partners, with whom we collaborated on over 20 posters. Discover findings shared at major conferences here. Photo taken by Ivar Pel Visiopharm and UMC Utrecht achieve breakthrough in AI-powered detection of breast cancer lymph node metastases Visiopharm’s AI APP was featured in Nature Cancer, thanks to UMC Utrecht's groundbreaking study on AI-powered detection of breast cancer lymph node metastases.  Read more about the breakthrough Launch of new HER2 APP  Fully automatic single-cell approach for HER2 IHC quantification that follows ASCO/CAP guidelines. Learn more about the APP Check out our HER2 ultralow study presented at SABC 2024: Download poster  Launch of new PACS/IMS integrations Seemless integration is key when using AI in the fully digital pathology lab. Visiopharm’s hassle-free integration in your PACS/IMS (e.g Sectra IDS7) allows a fully automated workflow from scanning to reviewing. Read more about the integrations Advanced spatial neighborhood capabilities    The latest version of Phenoplex introduced groundbreaking features for spatial neighborhood analysis, allowing users to define custom radii and quantify and visualize specific cellular neighbors.  Read more about the capabilities  Automated ROI/AOI analysis for GeoMx DSP users With our partnership with Bruker Spatial Biology (formerly Nanostring), GeoMx users can leverage Oncotopix® Discovery AI-driven software to enhance tissue segmentation, speed up the ROI selection process, and standardize GeoMx results. Learn more: partnership with Bruker Spatial Biology Qualitopix: Trust your staining through AI driven quantification and monitoring  In 2024, Qualitopix partnered with Grundium to help you standardize your tissue biomarker staining with a complete workflow from scanning to documentation.  Learn more: partnership with Grundium Successful Spatial Biology series We successfully concluded our 2024 Spatial Biology Masterclass Series, featuring seven expert-led sessions by renowned speakers such as Prof. Jared Burks, Dr. Janusz Franco-Barraza, OracleBio, and others. These masterclasses delved into advanced image analysis techniques and showcased the innovative applications of Phenoplex in spatial biology research.  Watch the recordings Visiopharm, Agern Allé 24, Hørsholm, - 2970, Denmark Unsubscribe Manage preferences Forward to a Friend |
| --- |